Towards a Race-Neutral System of Pulmonary Function Test Results Interpretation.
health equity
occupational medicine
pulmonary function test
race-neutral interpretation
spirometry
Journal
Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
29
04
2023
revised:
27
05
2023
accepted:
03
06
2023
pmc-release:
01
09
2024
medline:
11
9
2023
pubmed:
7
7
2023
entrez:
6
7
2023
Statut:
ppublish
Résumé
It has been observed widely that, on average, Black individuals in the United States have lower FVC than White individuals, which is thought to reflect a combination of genetic, environmental, and socioeconomic factors that are difficult to disentangle. Debate therefore persists even after the American Thoracic Society's 2023 guidelines recommending race-neutral pulmonary function test (PFT) result interpretation strategies. Advocates of race-based PFT results interpretation argue that it allows for more precise measurement and will minimize disease misclassification. In contrast, recent studies have shown that low lung function in Black patients has clinical consequences. Furthermore, the use of race-based algorithms in medicine in general is increasingly being questioned for its risk of perpetuating structural health care disparities. Given these concerns, we believe it is time to adopt a race-neutral approach, but note that more research is urgently needed to understand how race-neutral approaches impact PFT results interpretation, clinical decision-making, and patient outcomes. In this brief case-based discussion, we offer a few examples of how a race-neutral PFT results interpretation strategy will impact individuals from racial and ethnic minority groups at different scenarios and stages of life.
Identifiants
pubmed: 37414097
pii: S0012-3692(23)00805-X
doi: 10.1016/j.chest.2023.06.005
pmc: PMC10504596
pii:
doi:
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
727-733Subventions
Organisme : NIEHS NIH HHS
ID : K23 ES032459
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL066988
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL146942
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146002
Pays : United States
Informations de copyright
Copyright © 2023 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: A. B., A. A., and M. C. have received National Institutes of Health (NIH) funding for their general research programs (NIH 3U01HL146002 - 04W1 to A. B; NIH K23HL146942 to A. A.; NIH T32 HL066988 to M. C., for the training program at Rochester).None declared (D. C., K. P., M. C. M., S. N. G.).
Références
Chest. 1999 Nov;116(5):1183-93
pubmed: 10559074
Am J Respir Crit Care Med. 2022 Mar 15;205(6):700-710
pubmed: 34913853
Am J Surg. 2015 Apr;209(4):652-8
pubmed: 25812844
Environ Health Perspect. 2004 May;112(6):731-9
pubmed: 15121517
Chest. 2023 Jun 17;:
pubmed: 37421975
JAMA Netw Open. 2023 Mar 1;6(3):e232427
pubmed: 36897590
J Cardiothorac Surg. 2018 Jun 5;13(1):56
pubmed: 29871643
Lancet Respir Med. 2022 Feb;10(2):149-157
pubmed: 34739861
Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4296-301
pubmed: 27044069
Wilderness Environ Med. 2009 Summer;20(2):125-8
pubmed: 19594212
Pain Med. 2012 Feb;13(2):150-74
pubmed: 22239747
J Allergy Clin Immunol. 2012 Jun;129(6):1484-90.e6
pubmed: 22560959
J Clin Oncol. 2006 Jan 20;24(3):413-8
pubmed: 16365180
Race Soc Probl. 2019 Mar;11(1):60-67
pubmed: 31440306
Ann Intern Med. 2022 Aug;175(8):1118-1125
pubmed: 35849828
Am J Respir Crit Care Med. 2022 Apr 1;205(7):819-829
pubmed: 34913855
Chest. 1993 Sep;104(3):705-11
pubmed: 8365280
Health Care Manag (Frederick). 2017 Jan/Mar;36(1):29-38
pubmed: 27669426
RSF. 2019 Mar;5(2):123-140
pubmed: 31168473
Front Med (Lausanne). 2022 Mar 21;9:864658
pubmed: 35386918
J Occup Environ Med. 2014 Oct;56 Suppl 10:S23-9
pubmed: 25285971
Chest. 2013 May;143(5 Suppl):e166S-e190S
pubmed: 23649437
Occup Environ Med. 2018 Dec;75(12):871-876
pubmed: 30323012
Am J Respir Crit Care Med. 2022 Sep 15;206(6):790-792
pubmed: 35503241
Interact Cardiovasc Thorac Surg. 2016 Dec;23(6):889-894
pubmed: 27516423
Am J Respir Crit Care Med. 2023 Apr 15;207(8):978-995
pubmed: 36973004
N Engl J Med. 2020 Aug 27;383(9):874-882
pubmed: 32853499
Health Psychol. 2016 Sep;35(9):987-95
pubmed: 27175576
Chest. 2022 Jan;161(1):288-297
pubmed: 34437887
JAMA Netw Open. 2021 Jan 4;4(1):e2029238
pubmed: 33492373
Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1546-1553
pubmed: 34108139
Am J Respir Crit Care Med. 2022 Sep 15;206(6):789-790
pubmed: 35503517
N Engl J Med. 2020 Dec 17;383(25):2477-2478
pubmed: 33326721
BMC Pulm Med. 2021 Apr 27;21(1):139
pubmed: 33906617
Chest. 2023 Aug;164(2):461-475
pubmed: 36972760
Sports Med. 2003;33(2):109-16
pubmed: 12617690
Am J Respir Crit Care Med. 2023 Mar 15;207(6):768-774
pubmed: 36383197
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Occup Environ Med. 2014 Jun;71(6):388-97
pubmed: 24142974
Am J Respir Crit Care Med. 2022 Mar 15;205(6):723-724
pubmed: 34597248
Prev Chronic Dis. 2009 Jul;6(3):A105
pubmed: 19527577